COVID-19: CDC, FDA and CMS Guidance

Aug 27, 2021
The Centers for Disease Control and Prevention alerted health care providers and the public to reports of severe illness associated with using products containing ivermectin to prevent or treat COVID-19.
Aug 25, 2021
Health care providers should stop using N95 respirators made by Shanghai Dasheng Health Products Manufacturing Co. Ltd., which are no longer authorized for emergency use, the Food and Drug Administration announced.
Aug 24, 2021
The Centers for Disease Control and Prevention released research highlighting two important trends emerging from the COVID-19 pandemic regarding vaccines’ current effectiveness.
Aug 23, 2021
The Food and Drug Administration today granted full approval for the Pfizer-BioNTech COVID-19 vaccine for individuals age 16 and over. The vaccine, which will now be marketed as Comirnaty, is the first COVID-19 vaccine to go beyond emergency use status in the United States.
Aug 18, 2021
In evaluating whether to temporarily suspend survey activities if a hospital experiences a COVID-19 surge, the Centers for Medicare…
Aug 16, 2021
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., authorized a third, additional dose of the mRNA COVID-19 vaccines for people with moderately to severely compromised immune systems. This includes people who have:
Aug 13, 2021
There’s a lot of misinformation about COVID-19 vaccines. Get the facts from the experts at the Centers for Disease Control and Prevention and the American Medical Association.
Aug 13, 2021
The Food and Drug Administration announced amendments of Pfizer and Moderna’s COVID-19 vaccine emergency use authorizations to allow for the use of a third, additional dose for certain immunocompromised individuals.
Aug 6, 2021
The Centers for Disease Control and Prevention released a study confirming the comparative effectiveness of COVID-19 vaccines versus natural immunity, including immunity gained from prior SARS-CoV-2 infection.